{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:12:51Z","timestamp":1788221571743,"version":"build-2803163510"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Molecules that facilitate protein\u2013protein interactions are immensely impactful. However, such compounds typically rely on accessory proteins to function, such as E3 ligases for targeted degradation, which may restrict their scope or lead to resistance. We alleviate the need for accessory proteins with a strategy that exploits protein symmetry as a selective vulnerability and is widely applicable because of the ubiquitous nature of homomeric proteins. We target homomeric proteins with PINCHs (polymerization-inducing chimeras)\u2014bifunctional molecules composed of two linked ligands that bridge homomers and trigger their supramolecular assembly into insoluble polymers. We design PINCHs that achieve efficient polymerization of four targets. In cells, we observed that a PINCH targeting Keap1 exhibited a longer duration of action and a PINCH targeting BCL6 displayed selective lowering of B cell viability compared to their monomeric parents. Our results highlight PINCHs as a novel and general strategy to modulate and knock out protein function.<\/jats:p>","DOI":"10.1038\/s41589-026-02141-0","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:04:15Z","timestamp":1770285855000},"page":"1414-1424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A pharmacological modality to sequester homomeric proteins"],"prefix":"10.1038","volume":"22","author":[{"given":"Ella","family":"Livnah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohad","family":"Suss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Rogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2587-0071","authenticated-orcid":false,"given":"Atar","family":"Gilat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Abdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4488-347X","authenticated-orcid":false,"given":"Jos\u00e9 A.","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Gabizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almog","family":"Nadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Shamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam Y.","family":"Steinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barr","family":"Tivon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Albeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9793-236X","authenticated-orcid":false,"given":"Ofra","family":"Golani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Goliand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6222-2280","authenticated-orcid":false,"given":"Nadav","family":"Elad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2102-7723","authenticated-orcid":false,"given":"Silvia","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khriesto","family":"Shurrush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haim","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7831-6513","authenticated-orcid":false,"given":"David","family":"Margulies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8959-7365","authenticated-orcid":false,"given":"Emmanuel D.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2687-0699","authenticated-orcid":false,"given":"Nir","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"2141_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1074-5521(96)90249-5","volume":"3","author":"PJ Belshaw","year":"1996","unstructured":"Belshaw, P. J., Spencer, D. M., Crabtree, G. R. & Schreiber, S. L. Controlling programmed cell death with a cyclophilin\u2013cyclosporin-based chemical inducer of dimerization. Chem. Biol. 3, 731\u2013738 (1996).","journal-title":"Chem. Biol."},{"key":"2141_CR2","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1021\/ja963891c","volume":"119","author":"ST Diver","year":"1997","unstructured":"Diver, S. T. & Schreiber, S. L. Single-step synthesis of cell-permeable protein dimerizers that activate signal transduction and gene expression. J. Am. Chem. Soc. 119, 5106\u20135109 (1997).","journal-title":"J. Am. Chem. Soc."},{"key":"2141_CR3","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1021\/acscentsci.3c00395","volume":"9","author":"X Liu","year":"2023","unstructured":"Liu, X. & Ciulli, A. Proximity-based modalities for biology and medicine. ACS Cent. Sci. 9, 1269\u20131284 (2023).","journal-title":"ACS Cent. Sci."},{"key":"2141_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202300712","volume":"25","author":"DA Nalawansha","year":"2024","unstructured":"Nalawansha, D. A., Mangano, K., den Besten, W. & Potts, P. R. TAC-tics for leveraging proximity biology in drug discovery. ChemBioChem 25, e202300712 (2024).","journal-title":"ChemBioChem"},{"key":"2141_CR5","doi-asserted-by":"publisher","first-page":"e202312461","DOI":"10.1002\/anie.202312461","volume":"63","author":"O Suss","year":"2024","unstructured":"Suss, O. et al. Artificial protein crosstalk with a molecule that exchanges binding partners. Angew. Chem. Int. Ed. 63, e202312461 (2024).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2141_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2021.102107","volume":"67","author":"CSC Ng","year":"2022","unstructured":"Ng, C. S. C. & Banik, S. M. Recent advances in induced proximity modalities. Curr. Opin. Chem. Biol. 67, 102107 (2022).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"2141_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2141_CR8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.chembiol.2023.06.020","volume":"30","author":"M Teng","year":"2023","unstructured":"Teng, M. & Gray, N. S. The rise of degrader drugs. Cell Chem. Biol. 30, 864\u2013878 (2023).","journal-title":"Cell Chem. Biol."},{"key":"2141_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","volume":"584","author":"SM Banik","year":"2020","unstructured":"Banik, S. M. et al. Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature 584, 291\u2013297 (2020).","journal-title":"Nature"},{"key":"2141_CR10","doi-asserted-by":"publisher","first-page":"14052","DOI":"10.1021\/jacs.0c05537","volume":"142","author":"SU Siriwardena","year":"2020","unstructured":"Siriwardena, S. U. et al. Phosphorylation-inducing chimeric small molecules. J. Am. Chem. Soc. 142, 14052\u201314057 (2020).","journal-title":"J. Am. Chem. Soc."},{"key":"2141_CR11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41589-022-00971-2","volume":"18","author":"NJ Henning","year":"2022","unstructured":"Henning, N. J. et al. Deubiquitinase-targeting chimeras for targeted protein stabilization. Nat. Chem. Biol. 18, 412\u2013421 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"2141_CR12","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.chembiol.2024.07.005","volume":"31","author":"K Raina","year":"2024","unstructured":"Raina, K. et al. Regulated induced proximity targeting chimeras\u2014RIPTACs\u2014a heterobifunctional small molecule strategy for cancer selective therapies. Cell Chem. Biol. 31, 1490\u20131502 (2024).","journal-title":"Cell Chem. Biol."},{"key":"2141_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cell.2020.12.020","volume":"184","author":"SL Schreiber","year":"2021","unstructured":"Schreiber, S. L. The rise of molecular glues. Cell 184, 3\u20139 (2021).","journal-title":"Cell"},{"key":"2141_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41589-023-01409-z","volume":"20","author":"Z Kozicka","year":"2024","unstructured":"Kozicka, Z. et al. Design principles for cyclin K molecular glue degraders. Nat. Chem. Biol. 20, 93\u2013102 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"2141_CR15","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/anie.201507978","volume":"55","author":"M Toure","year":"2016","unstructured":"Toure, M. & Crews, C. M. Small-molecule PROTACS: new approaches to protein degradation. Angew. Chem. Int. Ed. 55, 1966\u20131973 (2016).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2141_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35795-8","volume":"14","author":"JM Lee","year":"2023","unstructured":"Lee, J. M., Hammar\u00e9n, H. M., Savitski, M. M. & Baek, S. H. Control of protein stability by post-translational modifications. Nat. Commun. 14, 201 (2023).","journal-title":"Nat. Commun."},{"key":"2141_CR17","doi-asserted-by":"publisher","first-page":"eado6492","DOI":"10.1126\/sciadv.ado6492","volume":"10","author":"C Crowe","year":"2024","unstructured":"Crowe, C. et al. Mechanism of degrader-targeted protein ubiquitinability. Sci. Adv. 10, eado6492 (2024).","journal-title":"Sci. Adv."},{"key":"2141_CR18","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/1535-7163.MCT-18-1129","volume":"18","author":"L Zhang","year":"2019","unstructured":"Zhang, L., Riley-Gillis, B., Vijay, P. & Shen, Y. Acquired resistance to BET-PROTACs (proteolysis-targeting chimeras) caused by genomic alterations in core components of E3 ligase complexes. Mol. Cancer Ther. 18, 1302\u20131311 (2019).","journal-title":"Mol. Cancer Ther."},{"key":"2141_CR19","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41586-024-07387-z","volume":"629","author":"N Diaz","year":"2024","unstructured":"Diaz, N. et al. Discovery of potent small-molecule inhibitors of lipoprotein(a) formation. Nature 629, 945\u2013950 (2024).","journal-title":"Nature"},{"key":"2141_CR20","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1073\/pnas.041614998","volume":"98","author":"JE Padilla","year":"2001","unstructured":"Padilla, J. E., Colovos, C. & Yeates, T. O. Nanohedra: using symmetry to design self assembling protein cages, layers, crystals, and filaments. Proc. Natl Acad. Sci. USA 98, 2217\u20132221 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR21","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1126\/science.1219364","volume":"336","author":"NP King","year":"2012","unstructured":"King, N. P. et al. Computational design of self-assembling protein nanomaterials with atomic level accuracy. Science 336, 1171\u20131174 (2012).","journal-title":"Science"},{"key":"2141_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41586-020-03120-8","volume":"589","author":"AJ Ben-Sasson","year":"2021","unstructured":"Ben-Sasson, A. J. et al. Design of biologically active binary protein 2D materials. Nature 589, 468\u2013473 (2021).","journal-title":"Nature"},{"key":"2141_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22276-z","volume":"12","author":"Y Hsia","year":"2021","unstructured":"Hsia, Y. et al. Design of multi-scale protein complexes by hierarchical building block fusion. Nat. Commun. 12, 2294 (2021).","journal-title":"Nat. Commun."},{"key":"2141_CR24","doi-asserted-by":"publisher","first-page":"e2101117119","DOI":"10.1073\/pnas.2101117119","volume":"119","author":"H Garcia Seisdedos","year":"2022","unstructured":"Garcia Seisdedos, H., Levin, T., Shapira, G., Freud, S. & Levy, E. D. Mutant libraries reveal negative design shielding proteinsfrom supramolecular self-assembly and relocalization in cells. Proc. Natl Acad. Sci. USA 119, e2101117119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2141_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nature23320","volume":"548","author":"H Garcia-Seisdedos","year":"2017","unstructured":"Garcia-Seisdedos, H., Empereur-Mot, C., Elad, N. & Levy, E. D. Proteins evolve on the edge of supramolecular self-assembly. Nature 548, 244\u2013247 (2017).","journal-title":"Nature"},{"key":"2141_CR26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41589-020-0576-z","volume":"16","author":"M Heidenreich","year":"2020","unstructured":"Heidenreich, M. et al. Designer protein assemblies with tunable phase diagrams in living cells. Nat. Chem. Biol. 16, 939\u2013945 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"2141_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature17633","volume":"533","author":"Y Suzuki","year":"2016","unstructured":"Suzuki, Y. et al. Self-assembly of coherently dynamic, auxetic, two-dimensional protein crystals. Nature 533, 369\u2013373 (2016).","journal-title":"Nature"},{"key":"2141_CR28","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.chembiol.2021.04.009","volume":"28","author":"Z Kozicka","year":"2021","unstructured":"Kozicka, Z. & Thom\u00e4, N. H. Haven\u2019t got a glue: protein surface variation for the design of molecular glue degraders. Cell Chem. Biol. 28, 1032\u20131047 (2021).","journal-title":"Cell Chem. Biol."},{"key":"2141_CR29","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1021\/cr400698c","volume":"114","author":"L-G Milroy","year":"2014","unstructured":"Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L. & Ottmann, C. Modulators of protein\u2013protein interactions. Chem. Rev. 114, 4695\u20134748 (2014).","journal-title":"Chem. Rev."},{"key":"2141_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41586-020-2925-1","volume":"588","author":"M S\u0142abicki","year":"2020","unstructured":"S\u0142abicki, M. et al. Small-molecule-induced polymerization triggers degradation of BCL6. Nature 588, 164\u2013168 (2020).","journal-title":"Nature"},{"key":"2141_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/B978-0-12-386931-9.00002-7","volume":"117","author":"ED Levy","year":"2013","unstructured":"Levy, E. D. & Teichmann, S. Structural, evolutionary, and assembly principles of protein oligomerization. Prog. Mol. Biol. Transl. Sci. 117, 25\u201351 (2013).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"2141_CR32","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.drudis.2021.01.028","volume":"26","author":"L Thabault","year":"2021","unstructured":"Thabault, L., Liberelle, M. & Fr\u00e9d\u00e9rick, R. Targeting protein self-association in drug design. Drug Discov. Today 26, 1148\u20131163 (2021).","journal-title":"Drug Discov. Today"},{"key":"2141_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1600-065X.2012.01112.x","volume":"247","author":"K Basso","year":"2012","unstructured":"Basso, K. & Dalla-Favera, R. Roles of BCL6 in normal and transformed germinal center B cells. Immunol. Rev. 247, 172\u2013183 (2012).","journal-title":"Immunol. Rev."},{"key":"2141_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/14728222.2018.1420782","volume":"22","author":"RJ Leeman-Neill","year":"2018","unstructured":"Leeman-Neill, R. J. & Bhagat, G. BCL6 as a therapeutic target for lymphoma. Expert Opin. Ther. Targets 22, 143\u2013152 (2018).","journal-title":"Expert Opin. Ther. Targets"},{"key":"2141_CR35","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1021\/acs.jmedchem.9b01618","volume":"63","author":"W Guo","year":"2020","unstructured":"Guo, W. et al. Synthesis and biological evaluation of B-cell lymphoma 6 inhibitors of N-phenyl-4-pyrimidinamine derivatives bearing potent activities against tumor growth. J. Med. Chem. 63, 676\u2013695 (2020).","journal-title":"J. Med. Chem."},{"key":"2141_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1021\/acsmedchemlett.2c00502","volume":"14","author":"A Mamai","year":"2023","unstructured":"Mamai, A. et al. Discovery of OICR12694: a novel, potent, selective, and orally bioavailable BCL6 BTB inhibitor. ACS Med. Chem. Lett. 14, 199\u2013210 (2023).","journal-title":"ACS Med. Chem. Lett."},{"key":"2141_CR37","doi-asserted-by":"publisher","first-page":"15559","DOI":"10.1021\/acs.jmedchem.2c01433","volume":"65","author":"H Gu","year":"2022","unstructured":"Gu, H. et al. B-cell lymphoma 6 inhibitors: current advances and prospects of drug development for diffuse large B-cell lymphomas. J. Med. Chem. 65, 15559\u201315583 (2022).","journal-title":"J. Med. Chem."},{"key":"2141_CR38","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1182\/blood-2021-149654","volume":"138","author":"SM Gough","year":"2021","unstructured":"Gough, S. M. et al. Potent and orally bioavailable BCL6 PROTAC TM degraders demonstrate efficacy in pre-clinical models of diffuse large B-cell lymphoma (DLBCL). Blood 138, 2272 (2021).","journal-title":"Blood"},{"key":"2141_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-023-06348-2","volume":"620","author":"S Gourisankar","year":"2023","unstructured":"Gourisankar, S. et al. Rewiring cancer drivers to activate apoptosis. Nature 620, 417\u2013425 (2023).","journal-title":"Nature"},{"key":"2141_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/science.adl5361","volume":"386","author":"RC Sarott","year":"2024","unstructured":"Sarott, R. C. et al. Relocalizing transcriptional kinases to activate apoptosis. Science 386, eadl5361 (2024).","journal-title":"Science"},{"key":"2141_CR41","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1021\/acsmedchemlett.0c00111","volume":"11","author":"M Teng","year":"2020","unstructured":"Teng, M. et al. Rationally designed covalent BCL6 inhibitor that targets a tyrosine residue in the homodimer interface. ACS Med. Chem. Lett. 11, 1269\u20131273 (2020).","journal-title":"ACS Med. Chem. Lett."},{"key":"2141_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","volume":"13","author":"AL Shaffer","year":"2000","unstructured":"Shaffer, A. L. et al. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13, 199\u2013212 (2000).","journal-title":"Immunity"},{"key":"2141_CR43","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41573-019-0047-y","volume":"18","author":"M Schapira","year":"2019","unstructured":"Schapira, M., Calabrese, M. F., Bullock, A. N. & Crews, C. M. Targeted protein degradation: expanding the toolbox. Nat. Rev. Drug Discov. 18, 949\u2013963 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2141_CR44","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1080\/17460441.2019.1659242","volume":"14","author":"M Konstantinidou","year":"2019","unstructured":"Konstantinidou, M. et al. PROTACs\u2014a game-changing technology. Expert Opin. Drug Discov. 14, 1255\u20131268 (2019).","journal-title":"Expert Opin. Drug Discov."},{"key":"2141_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202300163","volume":"24","author":"JA Ward","year":"2023","unstructured":"Ward, J. A., Perez-Lopez, C. & Mayor-Ruiz, C. Biophysical and computational approaches to study ternary complexes: a \u2018cooperative relationship\u2019 to rationalize targeted protein degradation. ChemBioChem 24, e202300163 (2023).","journal-title":"ChemBioChem"},{"key":"2141_CR46","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1016\/j.celrep.2017.08.081","volume":"20","author":"N Kerres","year":"2017","unstructured":"Kerres, N. et al. Chemically induced degradation of the oncogenic transcription factor BCL6. Cell Rep. 20, 2860\u20132875 (2017).","journal-title":"Cell Rep."},{"key":"2141_CR47","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.molmed.2004.09.003","volume":"10","author":"H Motohashi","year":"2004","unstructured":"Motohashi, H. & Yamamoto, M. Nrf2\u2013Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10, 549\u2013557 (2004).","journal-title":"Trends Mol. Med."},{"key":"2141_CR48","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","volume":"47","author":"JW Kaspar","year":"2009","unstructured":"Kaspar, J. W., Niture, S. K. & Jaiswal, A. K. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic. Biol. Med. 47, 1304\u20131309 (2009).","journal-title":"Free Radic. Biol. Med."},{"key":"2141_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","volume":"88","author":"T Suzuki","year":"2015","unstructured":"Suzuki, T. & Yamamoto, M. Molecular basis of the Keap1\u2013Nrf2 system. Free Radic. Biol. Med. 88, 93\u2013100 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"2141_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/B978-0-12-398339-8.00002-1","volume":"63","author":"IM Copple","year":"2012","unstructured":"Copple, I. M. The Keap1\u2013Nrf2 cell defense pathway\u2014a promising therapeutic target? Adv. Pharmacol. 63, 43\u201379 (2012).","journal-title":"Adv. Pharmacol."},{"key":"2141_CR51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/med.21925","volume":"43","author":"E Crisman","year":"2023","unstructured":"Crisman, E. et al. Keap1\u2013Nrf2 protein\u2013protein interaction inhibitors: design, pharmacological properties and therapeutic potential. Med. Res. Rev. 43, 237\u2013287 (2023).","journal-title":"Med. Res. Rev."},{"key":"2141_CR52","first-page":"2075","volume":"8","author":"Y-Y Wang","year":"2014","unstructured":"Wang, Y.-Y., Yang, Y.-X., Zhe, H., He, Z.-X. & Zhou, S.-F. Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties. Drug Des. Devel. Ther. 8, 2075\u20132088 (2014).","journal-title":"Drug Des. Devel. Ther."},{"key":"2141_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098896","volume":"9","author":"A Cleasby","year":"2014","unstructured":"Cleasby, A. et al. Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO. PLoS ONE 9, e98896 (2014).","journal-title":"PLoS ONE"},{"key":"2141_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08027-7","volume":"10","author":"BE Smith","year":"2019","unstructured":"Smith, B. E. et al. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase. Nat. Commun. 10, 131 (2019).","journal-title":"Nat. Commun."},{"key":"2141_CR55","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1039\/D2CS00200K","volume":"51","author":"RG Guenette","year":"2022","unstructured":"Guenette, R. G., Yang, S. W., Min, J., Pei, B. & Potts, P. R. Target and tissue selectivity of PROTAC degraders. Chem. Soc. Rev. 51, 5740\u20135756 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"2141_CR56","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"2141_CR57","doi-asserted-by":"publisher","first-page":"D358","DOI":"10.1093\/nar\/gkt1115","volume":"42","author":"S Orchard","year":"2014","unstructured":"Orchard, S. et al. The MIntAct project\u2014IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res. 42, D358\u2013D363 (2014).","journal-title":"Nucleic Acids Res."},{"key":"2141_CR58","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejmech.2018.01.063","volume":"146","author":"M Lu","year":"2018","unstructured":"Lu, M. et al. Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway. Eur. J. Med. Chem. 146, 251\u2013259 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"2141_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72491-9","volume":"10","author":"B Tong","year":"2020","unstructured":"Tong, B. et al. Bardoxolone conjugation enables targeted protein degradation of BRD4. Sci. Rep. 10, 15543 (2020).","journal-title":"Sci. Rep."},{"key":"2141_CR60","doi-asserted-by":"publisher","first-page":"15073","DOI":"10.1021\/jacs.1c04841","volume":"143","author":"J Wei","year":"2021","unstructured":"Wei, J. et al. Harnessing the E3 ligase Keap1 for targeted protein degradation. J. Am. Chem. Soc. 143, 15073\u201315083 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"2141_CR61","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.chembiol.2022.08.003","volume":"29","author":"G Du","year":"2022","unstructured":"Du, G. et al. Exploring the target scope of Keap1 E3 ligase-based PROTACs. Cell Chem. Biol. 29, 1470\u20131481.e31 (2022).","journal-title":"Cell Chem. Biol."},{"key":"2141_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00954-1","volume":"8","author":"C Maniaci","year":"2017","unstructured":"Maniaci, C. et al. Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation. Nat. Commun. 8, 830 (2017).","journal-title":"Nat. Commun."},{"key":"2141_CR63","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1021\/acschembio.8b00693","volume":"13","author":"C Steinebach","year":"2018","unstructured":"Steinebach, C. et al. Homo-PROTACs for the chemical knockdown of Cereblon. ACS Chem. Biol. 13, 2771\u20132782 (2018).","journal-title":"ACS Chem. Biol."},{"key":"2141_CR64","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.apsb.2020.11.022","volume":"11","author":"S He","year":"2021","unstructured":"He, S. et al. Homo-PROTAC mediated suicide of MDM2 to treat non-small cell lung cancer. Acta Pharm. Sin. B 11, 1617\u20131628 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"2141_CR65","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41589-024-01760-9","volume":"21","author":"AR Julio","year":"2025","unstructured":"Julio, A. R. et al. Delineating cysteine-reactive compound modulation of cellular proteostasis processes. Nat. Chem. Biol. 21, 693\u2013705 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"2141_CR66","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1042\/bj20030754","volume":"374","author":"P Nioi","year":"2003","unstructured":"Nioi, P., McMahon, M., Itoh, K., Yamamoto, M. & Hayes, J. D. Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem. J. 374, 337\u2013348 (2003).","journal-title":"Biochem. J."},{"key":"2141_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101950","volume":"41","author":"D Ross","year":"2021","unstructured":"Ross, D. & Siegel, D. The diverse functionality of NQO1 and its roles in redox control. Redox Biol. 41, 101950 (2021).","journal-title":"Redox Biol."},{"key":"2141_CR68","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molmed.2023.12.002","volume":"30","author":"F Pilotto","year":"2024","unstructured":"Pilotto, F., Chellapandi, D. M. & Puccio, H. Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia. Trends Mol. Med. 30, 117\u2013125 (2024).","journal-title":"Trends Mol. Med."},{"key":"2141_CR69","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF02910016","volume":"5","author":"LE Miles","year":"1975","unstructured":"Miles, L. E. Properties, variants, and applications of the immunoradiometric assay method. Ric. Clin. Lab. 5, 59\u201372 (1975).","journal-title":"Ric. Clin. Lab."},{"key":"2141_CR70","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1021\/ja311795d","volume":"135","author":"EF Douglass","year":"2013","unstructured":"Douglass, E. F. et al. A comprehensive mathematical model for three-body binding equilibria. J. Am. Chem. Soc. 135, 6092\u20136099 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"2141_CR71","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1021\/jm201734r","volume":"55","author":"RA Ward","year":"2012","unstructured":"Ward, R. A. et al. Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation. J. Med. Chem. 55, 3285\u20133306 (2012).","journal-title":"J. Med. Chem."},{"key":"2141_CR72","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1523\/JNEUROSCI.1243-20.2020","volume":"40","author":"NL Gould","year":"2020","unstructured":"Gould, N. L. et al. Dopamine-dependent QR2 pathway activation in CA1 interneurons enhances novel memory formation. J. Neurosci. 40, 8698\u20138714 (2020).","journal-title":"J. Neurosci."},{"key":"2141_CR73","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1124\/molpharm.120.000105","volume":"98","author":"E Janda","year":"2020","unstructured":"Janda, E., Nepveu, F., Calamini, B., Ferry, G. & Boutin, J. A. Molecular pharmacology of NRH:quinone oxidoreductase 2: a detoxifying enzyme acting as an undercover toxifying enzyme. Mol. Pharmacol. 98, 620\u2013633 (2020).","journal-title":"Mol. Pharmacol."},{"key":"2141_CR74","doi-asserted-by":"publisher","first-page":"e162120","DOI":"10.1172\/JCI162120","volume":"133","author":"NL Gould","year":"2023","unstructured":"Gould, N. L. et al. Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer\u2019s disease phenotype in mice. J. Clin. Invest. 133, e162120 (2023).","journal-title":"J. Clin. Invest."},{"key":"2141_CR75","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41587-022-01586-7","volume":"41","author":"C Linghu","year":"2023","unstructured":"Linghu, C. et al. Recording of cellular physiological histories along optically readable self-assembling protein chains. Nat. Biotechnol. 41, 640\u2013651 (2023).","journal-title":"Nat. Biotechnol."},{"key":"2141_CR76","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41587-022-01524-7","volume":"41","author":"D Lin","year":"2023","unstructured":"Lin, D. et al. Time-tagged ticker tapes for intracellular recordings. Nat. Biotechnol. 41, 631\u2013639 (2023).","journal-title":"Nat. Biotechnol."},{"key":"2141_CR77","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/s44320-025-00144-y","volume":"21","author":"T Levin","year":"2025","unstructured":"Levin, T. et al. Mutation-induced filaments of folded proteins are inert and non-toxic in a cellular system. Mol. Syst. Biol. 21, 1306\u20131324 (2025).","journal-title":"Mol. Syst. Biol."},{"key":"2141_CR78","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1002\/anie.201806092","volume":"58","author":"H Garcia-Seisdedos","year":"2019","unstructured":"Garcia-Seisdedos, H., Villegas, J. A. & Levy, E. D. Infinite assembly of folded proteins in evolution, disease, and engineering. Angew. Chem. Int. Ed. 58, 5514\u20135531 (2019).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2141_CR79","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.sbi.2016.07.003","volume":"39","author":"TO Yeates","year":"2016","unstructured":"Yeates, T. O., Liu, Y. & Laniado, J. The design of symmetric protein nanomaterials comes of age in theory and practice. Curr. Opin. Struct. Biol. 39, 134\u2013143 (2016).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2141_CR80","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.chembiol.2023.12.005","volume":"31","author":"M Lu","year":"2024","unstructured":"Lu, M. et al. Bivalent inhibitors of the BTB E3 ligase Keap1 enable instant Nrf2 activation to suppress acute inflammatory response. Cell Chem. Biol. 31, 1188\u20131202 (2024).","journal-title":"Cell Chem. Biol."},{"key":"2141_CR81","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41589-019-0279-5","volume":"15","author":"X Zhang","year":"2019","unstructured":"Zhang, X., Crowley, V. M., Wucherpfennig, T. G., Dix, M. M. & Cravatt, B. F. Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16. Nat. Chem. Biol. 15, 737\u2013746 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"2141_CR82","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1021\/jacs.1c00990","volume":"143","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. DCAF11 supports targeted protein degradation by electrophilic proteolysis-targeting chimeras. J. Am. Chem. Soc. 143, 5141\u20135149 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"2141_CR83","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1021\/acs.chemrev.4c00570","volume":"125","author":"N London","year":"2025","unstructured":"London, N. Covalent proximity inducers. Chem. Rev. 125, 326\u2013368 (2025).","journal-title":"Chem. Rev."},{"key":"2141_CR84","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2024.01.022","volume":"187","author":"H Schweke","year":"2024","unstructured":"Schweke, H. et al. An atlas of protein homo-oligomerization across domains of life. Cell 187, 999\u20131010.e15 (2024).","journal-title":"Cell"},{"key":"2141_CR85","first-page":"4236","volume":"62","author":"B Nagar","year":"2002","unstructured":"Nagar, B. et al. Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). Cancer Res. 62, 4236\u20134243 (2002).","journal-title":"Cancer Res."},{"key":"2141_CR86","doi-asserted-by":"publisher","first-page":"8120","DOI":"10.1021\/acs.jmedchem.8b01040","volume":"61","author":"J Schoepfer","year":"2018","unstructured":"Schoepfer, J. et al. Discovery of asciminib (ABL001), an allosteric inhibitor of the tyrosine kinase activity of BCR\u2013ABL1. J. Med. Chem. 61, 8120\u20138135 (2018).","journal-title":"J. Med. Chem."},{"key":"2141_CR87","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nmeth.4256","volume":"14","author":"AT Kong","year":"2017","unstructured":"Kong, A. T., Leprevost, F. V., Avtonomov, D. M., Mellacheruvu, D. & Nesvizhskii, A. I. MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics. Nat. Methods 14, 513\u2013520 (2017).","journal-title":"Nat. Methods"},{"key":"2141_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2021.100077","volume":"20","author":"F Yu","year":"2021","unstructured":"Yu, F., Haynes, S. E. & Nesvizhskii, A. I. IonQuant enables accurate and sensitive label-free quantification with FDR-controlled match-between-runs. Mol. Cell. Proteomics 20, 100077 (2021).","journal-title":"Mol. Cell. Proteomics"},{"key":"2141_CR89","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731\u2013740 (2016).","journal-title":"Nat. Methods"},{"key":"2141_CR90","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. B 57"},{"key":"2141_CR91","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."},{"key":"2141_CR92","doi-asserted-by":"publisher","first-page":"11734","DOI":"10.1021\/jacs.9b13907","volume":"142","author":"R Gabizon","year":"2020","unstructured":"Gabizon, R. et al. Efficient targeted degradation via reversible and irreversible covalent PROTACs. J. Am. Chem. Soc. 142, 11734\u201311742 (2020).","journal-title":"J. Am. Chem. Soc."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02141-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02141-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02141-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:13:03Z","timestamp":1787577183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02141-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":92,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2141"],"URL":"https:\/\/doi.org\/10.1038\/s41589-026-02141-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.05.641597","asserted-by":"object"}]},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.L., O.S., A.G., J.A.V., D.M., E.D.L. and N.L. are inventors on a patent application covering the described technology. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}